KIAA1191 antibody
Principal name
KIAA1191 antibody
Alternative names for KIAA1191 antibody
UPF0498 protein KIAA1191, p60MONOX, Brain-derived rescue factor p60MONOX
SwissProt ID
Q32NP7 (Xenla), Q3T044 (Bovin), Q5F368 (Chick), Q5U2R6 (Rat), Q96A73 (Human), Q9DBN4 (Mouse)
Ncbi ID
9606, NP_001073153, NM_001079684, NP_065177, NP_001073152.1, NP_598558.1, NM_133797, NM_001014007, NM_001079685, NM_020444
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of KIAA1191 antibody
- Kit Component:
- - KN300335G1, 4833439L19Rik gRNA vector 1 in pCas-Guide vector
- KN300335G2, 4833439L19Rik gRNA vector 2 in pCas-Guide vector
- KN300335D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human Heart; WB Suggested Anti-KIAA1191 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human heart; KIAA1191 antibody - middle region (ARP56289_P050) in Human Heart cells using Western Blot
Human Placenta; WB Suggested Anti-KIAA1191 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human Placenta; KIAA1191 antibody - middle region (ARP56290_P050) in Human Placenta cells using Western Blot
WB Suggested Anti-KIAA1191 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: Human heart
WB Suggested Anti-KIAA1191 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: Human Placenta
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP303372 | KIAA1191 (transcript variant 3) |
||||
| Recombinant protein of human KIAA1191 (KIAA1191), transcript variant 3 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP318066 | KIAA1191 (transcript variant 1) |
||||
| Recombinant protein of human KIAA1191 (KIAA1191), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY421535 | KIAA1191 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425891 | KIAA1191 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC224240L2V | Lenti ORF particles, KIAA1191 (mGFP-tagged) - Human KIAA1191 (KIAA1191), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,020.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR204238L2V | Lenti ORF particles, 4833439L19Rik (GFP-tagged) - Mouse RIKEN cDNA 4833439L19 gene (4833439L19Rik), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR204238L1V | Lenti ORF particles, 4833439L19Rik (Myc-DDK-tagged) - Mouse RIKEN cDNA 4833439L19 gene (4833439L19Rik), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR207963L2V | Lenti ORF particles, LOC306766 (GFP-tagged ORF) - Rat hypothetical LOC306766 (LOC306766), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR207963L1V | Lenti ORF particles, LOC306766 (Myc-DDK-tagged ORF) - Rat hypothetical LOC306766 (LOC306766), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||